保瑞 News Releases

Bora Biologics Holdings, LLC Announces Cash Capital Increase for Subsidiary Bora Biologics USA, LLC

Bora Biologics Holdings, LLC, a subsidiary of Powertech, announced a cash capital increase of USD 86… · 2026-06-18

Hwalee Announces Endorsement Guarantee to Subsidiary Reaching Thresholds under Paragraph 1, Article 25, Clauses 2-4 of the 'Guidelines for Lending and Endorsement Guarantees by Publicly Issued Companies'

Hwalee announced on June 18, 2026, that its endorsement guarantee balance to its indirectly 100%-own… · 2026-06-18

Baorui Announces Guarantees to Subsidiary Reaching the Threshold under Article 25, Paragraph 1, Items 2 and 4 of the Regulations for Public Companies on Fund Lending and Guarantee Practices

Baorui announced on June 18, 115, that it has increased guarantees to its wholly-owned subsidiary Bo… · 2026-06-18

Far Eastern Biotech Announces Endorsement Guarantee to Subsidiary Reaches Threshold under Paragraph 4, Article 25, Clause 1 of the Handling Principles for Loans and Endorsement Guarantees by Publicly Issued Companies

Far Eastern Biotech has announced a new endorsement guarantee of NT$947.4 million to its indirect su… · 2026-06-18

Baorui Announces Fourth Audit Committee Members and Elected Convener

Baorui has announced the renewal of its Fourth Audit Committee due to term expiration, with new memb… · 2026-06-18

Pouyue Announces Appointment of Third Sustainable Development Committee Members

Pouyue announces changes to its Sustainable Development Committee due to the expiration of directors… · 2026-06-18

Baorui Announces Appointment of Sixth Compensation Committee Members

Baorui announced on 115/06/18 the appointment of new members to its Sixth Compensation Committee. Li… · 2026-06-18

Far Eastern Biotech Announces Substantial Intercompany Loans Under Taiwan's Public Company Lending Guidelines

Far Eastern Biotech and its subsidiaries have extended loans totaling NT$4.94 billion to affiliated … · 2026-06-18

Bora Pharmaceuticals USA Announces Cash Capital Increase for Subsidiary Bora Biologics Holdings, LLC

Bora Pharmaceuticals USA Inc., a key subsidiary of Polpharma, has announced a cash capital increase … · 2026-06-18

Bora Pharmaceutical Holdings, LLC, a Key Subsidiary of Powarui, Announces Acquisition of U.S. Drug Approval and Related Rights

Bora Pharmaceutical Holdings, LLC, a significant subsidiary of Powarui, has acquired the U.S. regula… · 2026-06-18

[Bora] Subsidiary Bora Global Ltd. Announces Fund Lending to Bora Pharmaceuticals USA Inc. under Public Company Fund Lending and Guarantee Regulations

Bora Global Ltd., a subsidiary of Bora, has provided a loan of NT$2.57 billion to its U.S. subsidiar… · 2026-06-18

[Bora] Company Invited to Participate in Goldman Sachs' GS China Healthcare Corporate Day Jun 2026

Bora Pharmaceuticals has been invited to participate in the GS China Healthcare Corporate Day event … · 2026-06-10

[BORA] Subsidiary TWi Pharmaceuticals USA, Inc. Announces Filing Pursuant to Article 22, Paragraph 1, Item 3 of the "Regulations Governing the Handling of Loans and Endorsements and Guarantees by Publicly Issued Companies"

BORA's subsidiary, TWi Pharmaceuticals USA, Inc., announced a loan of approximately NT$411.71 millio… · 2026-06-10

[Bora] Announcement of Important Resolutions from the 115th Annual General Meeting of Shareholders

Bora announced key resolutions passed at its 115th Annual General Meeting of Shareholders. These inc… · 2026-06-09

【Bora】Announcement of the Company's Invitation to Participate in an Investor Conference Hosted by Yuanta Securities

Bora has been invited by Yuanta Securities to participate in the Q2 2026 Investment Forum, holding a… · 2026-06-09

[Cosmos Pharmaceuticals] Board of Directors Re-elects Mr. Sheng Bao-Hsi as Chairman

Cosmos Pharmaceuticals' Board of Directors resolved on June 9, 115 (2026) to re-elect Mr. Sheng Bao-… · 2026-06-09

Bora Pharmaceuticals Announces Shareholder Approval for Waiver of Non-Competition Restrictions for Directors

Bora Pharmaceuticals announced that its shareholders' meeting approved the waiver of non-competition… · 2026-06-09

[Bora] Announcement of Elected Directors (Including Independent Directors) in the Full Board Election at the 115th Annual General Meeting

Bora Pharmaceuticals announced on June 9, 115, the results of its full board election following the … · 2026-06-09

【Prorize】Announcement of Company's Participation in Investor Conference Invited by First Golden Securities

Prorize announced its participation in the Q2 2026 Investment Forum hosted by First Golden Securitie… · 2026-06-03

【Prorize】Announcement of Company's Participation in Investor Conference Invited by First Golden Securities

Prorize announced its participation in the Q2 2026 Investment Forum hosted by First Golden Securitie… · 2026-06-03

[Bora] Announcement regarding the completion of registration for capital reduction via cancellation of restricted employee shares

Bora Pharmaceuticals announced that on May 20, 2026, it completed the registration for a capital red… · 2026-05-21

Bora Pharmaceuticals Subsidiary Signs 10-Year Long-Term Manufacturing Agreement with Top 20 Global Pharma Company

Bora Corporation's subsidiary, Bora Pharmaceuticals Inc., has signed a 10-year long-term contract ma… · 2026-05-18

【Bora】Subsidiary Bora Pharmaceuticals Inc. Announces Signing of Long-Term Manufacturing Agreement

Bora's subsidiary, Bora Pharmaceuticals Inc., has signed a 10-year long-term manufacturing agreement… · 2026-05-18

【BORA】Bora Pharmaceutical 2026 Q1 Online English Institutional Investor Conference

Bora Pharmaceutical announced that it will hold its Q1 2026 Online English Institutional Investor Co… · 2026-05-14

【BORA】Bora Pharmaceutical 2026 Q1 Online English Institutional Investor Conference

Bora Pharmaceutical announced that it will hold its Q1 2026 Online English Institutional Investor Co… · 2026-05-14

Bora Pharmaceuticals Announces Guarantee Balance to Subsidiary Reaches Article 25, Paragraph 1, Subparagraph 3 of the 'Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies'

Bora Pharmaceuticals announced that its endorsement/guarantee balance for its subsidiary, Upsher-Smi… · 2026-05-13

Bora Pharmaceuticals Board Approves Buyback of 200,000 Shares for Employee Transfer

Bora Pharmaceuticals Co., Ltd. announced that its board of directors resolved on May 13, 2026 to rep… · 2026-05-13

Bora Pharmaceuticals Board Approves Buyback of 200,000 Shares for Employee Transfer

Bora Pharmaceuticals Co., Ltd. announced that its board of directors resolved on May 13, 2026 to rep… · 2026-05-13

[Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report

Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For… · 2026-05-13

【BORA】Announcement of Company Invited by Taishin Securities to Participate in Institutional Investor Conference

Bora announced that it has been invited by Taishin Securities to hold an institutional investor conf… · 2026-05-13

【BORA】Announcement of Company Invited by Taishin Securities to Participate in Institutional Investor Conference

Bora announced that it has been invited by Taishin Securities to hold an institutional investor conf… · 2026-05-13

[Bora] Announcement of the Board's approval of the Q1 2026 consolidated financial report

Bora Pharmaceuticals announced its Q1 2026 consolidated financial results approved by the Board. For… · 2026-05-13

Bora Pharmaceutical: Announcement on Subsidiary Endorsement Guarantee Balance Reaching Article 25, Paragraph 1, Subparagraph 4 of the 'Regulations Governing the Lending of Funds and Making of Endorsements/Guarantees by Public Companies'

Bora Pharmaceutical announced that its endorsement guarantee balance to its subsidiary, Bora Global … · 2026-05-13

Bora Pharmaceutical: Announcement on Subsidiary Endorsement Guarantee Balance Reaching Article 25, Paragraph 1, Subparagraph 4 of the 'Regulations Governing the Lending of Funds and Making of Endorsements/Guarantees by Public Companies'

Bora Pharmaceutical announced that its endorsement guarantee balance to its subsidiary, Bora Global … · 2026-05-13

Bora Pharmaceuticals Announces Guarantee Balance to Subsidiary Reaches Article 25, Paragraph 1, Subparagraph 3 of the 'Regulations Governing Loaning of Funds and Making of Endorsements/Guarantees by Public Companies'

Bora Pharmaceuticals announced that its endorsement/guarantee balance for its subsidiary, Upsher-Smi… · 2026-05-13

Bora Announces Subsidiary Endorsement and Guarantee Balance Reaches 'Regulations Governing Fund Lending and Endorsement Guarantees by Publicly Issuing Companies' Article 25, Paragraph 1, Item 1

Bora announced on May 11, 2026, an increase in its subsidiary endorsement and guarantee balances, wi… · 2026-05-11

[Bora] Acquires CDMO Operating Assets Through Newly Established Subsidiary Bora Biologics USA LLC

Bora is acquiring CDMO operating assets in Maryland, USA, for USD 122.5 million through its newly es… · 2026-05-11

[Bora] Announcement and Filing Regarding "Regulations Governing Loans and Guarantees by Public Companies" Article 25, Paragraph 1, Items 2 and 4

Bora announces an increased guarantee for its subsidiary Bora Biologics USA LLC, amounting to approx… · 2026-05-11

[Bora] Announcement of Board Resolution on Cash Capital Increase for Subsidiary Bora Pharmaceuticals USA Inc.

Bora announced a USD 122.5 million cash capital increase for its subsidiary Bora Pharmaceuticals USA… · 2026-05-11

Bora Pharmaceuticals Announces Subsidiary Endorsement Guarantees Reach 78.11% of Net Worth

Bora Pharmaceuticals announced that as of May 11, 2026, its total endorsement guarantee balance for … · 2026-05-11

[Bora] Acquires CDMO Operating Assets Through Newly Established Subsidiary Bora Biologics USA LLC

Bora is acquiring CDMO operating assets in Maryland, USA, for USD 122.5 million through its newly es… · 2026-05-11

[Bora] Announcement and Filing Regarding "Regulations Governing Loans and Guarantees by Public Companies" Article 25, Paragraph 1, Items 2 and 4

Bora announces an increased guarantee for its subsidiary Bora Biologics USA LLC, amounting to approx… · 2026-05-11

[Bora] Announcement of Board Resolution on Cash Capital Increase for Subsidiary Bora Pharmaceuticals USA Inc.

Bora announced a USD 122.5 million cash capital increase for its subsidiary Bora Pharmaceuticals USA… · 2026-05-11

【Bora】Announcement of the Company's Invitation to Participate in an Investor Conference Hosted by Yuanta Securities

Bora has been invited by Yuanta Securities to participate in the Q2 2026 Investment Forum, holding a… · 2026-05-05

Baorui Announces Expected Date for Board Meeting to Review Q1 2026 Consolidated Financial Report

Baorui Company expects to hold its board meeting on May 13, 2026, to review the Q1 consolidated fina… · 2026-05-05

Baorui Announces Board Resolution for Repurchase and Cancellation of Restricted Employee Stock Options

Baorui's board of directors has resolved to repurchase and cancel restricted employee stock options … · 2026-05-05

Baorui Announces Expected Date for Board Meeting to Review Q1 2026 Consolidated Financial Report

Baorui Company expects to hold its board meeting on May 13, 2026, to review the Q1 consolidated fina… · 2026-05-05

Baorui Announces Board Resolution for Repurchase and Cancellation of Restricted Employee Stock Options

Baorui's board of directors has resolved to repurchase and cancel restricted employee stock options … · 2026-05-05

[Poray] Announcement: Subsidiary Poray Management Consulting Co., Ltd. Resolves to Subscribe to Private Placement Common Shares of Morning Sun Biotechnology Co., Ltd.

Poray announced that its subsidiary, Poray Management Consulting Co., Ltd., will subscribe to privat… · 2026-05-05

[Poray] Announcement: Subsidiary Poray Management Consulting Co., Ltd. Resolves to Subscribe to Private Placement Common Shares of Morning Sun Biotechnology Co., Ltd.

Poray announced that its subsidiary, Poray Management Consulting Co., Ltd., will subscribe to privat… · 2026-05-05

[Poray] Announcement: Board of Directors Resolves on Cash Capital Increase for Subsidiary Poray Management Consulting Co., Ltd.

Poray announced its board of directors has approved a cash capital increase for its wholly-owned sub… · 2026-05-05

[Poray] Announcement: Board of Directors Resolves on Base Date for Capital Increase Through Employee Stock Option Conversion to Common Stock

Poray's board of directors has set May 5, 2026, as the base date for a capital increase through the … · 2026-05-05

[Poray] Announcement: Board of Directors Resolves on Base Date for Capital Increase Through Employee Stock Option Conversion to Common Stock

Poray's board of directors has set May 5, 2026, as the base date for a capital increase through the … · 2026-05-05

[Poray] Announcement: Board of Directors Resolves on Cash Capital Increase for Subsidiary Poray Management Consulting Co., Ltd.

Poray announced its board of directors has approved a cash capital increase for its wholly-owned sub… · 2026-05-05

[Bora] May 2026 Revenue Reaches NTD 2.11 Billion (Up 40.2% YoY)

Bora Pharmaceuticals announced its May 2026 revenue of NTD 2,114,486 thousand (approx. NTD 2.11 bill… · 2026-05-01

[Bora Pharmaceuticals] April 2026 Monthly Revenue: NT$1.484 Billion (YoY -27.5%)

Bora Pharmaceuticals announced its monthly revenue for April 2026 was NT$1.484 billion. This represe… · 2026-04-01

[Bora Pharmaceuticals] April 2026 Monthly Revenue: NT$1.484 Billion (YoY -27.5%)

Bora Pharmaceuticals announced its monthly revenue for April 2026 was NT$1.484 billion. This represe… · 2026-04-01

[Boray] Announcement of Board Resolution to Convene the 115th Annual General Meeting of Shareholders (Updated Agenda Item 3)

Boray's Board of Directors has resolved to hold the annual general meeting of shareholders on June 9… · 2026-03-31

[Boray] Announcement of Board Resolution to Convene the 115th Annual General Meeting of Shareholders (Updated Agenda Item 3)

Boray's Board of Directors has resolved to hold the annual general meeting of shareholders on June 9… · 2026-03-31

Boray Announces March 2026 Revenue of NT$1.528 Billion, Up 6.3% Year-on-Year

Boray (Stock Code: 6472), a company in the biotech and healthcare sector, reported its March 2026 re… · 2026-03-01

Boray Announces March 2026 Revenue of NT$1.528 Billion, Up 6.3% Year-on-Year

Boray (Stock Code: 6472), a company in the biotech and healthcare sector, reported its March 2026 re… · 2026-03-01

【Bora Pharma】February 2026 Revenue: NT$1.326 Billion (YoY -23.2%)

Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2… · 2026-02-01

【Bora Pharma】February 2026 Revenue: NT$1.326 Billion (YoY -23.2%)

Bora Pharmaceuticals released its revenue report for February 2026, posting NT$1.326 billion, a 23.2… · 2026-02-01